Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02900560
Title Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Translational Research in Oncology
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.